eP201: A phase 2 clinical trial evaluating the safety and efficacy of delandistrogene moxeparvovec for treating patients with Duchenne muscular dystrophy

Saved in:
Bibliographic Details
Published in:Genetics in medicine Vol. 24; no. 3; p. S124
Main Authors: O'Rourke, Erin, Mendell, Jerry, Shieh, Perry, Sahenk, Zarife, Lehman, Kelly, Lowes, Linda, Reash, Natalie, Iammarino, Megan, Alfano, Lindsay, Powers, Brenna, Woods, Jeremy, Skura, Christy, Mao, Howard, Staudt, Loretta, Potter, Rachael, Griffin, Danielle, Lewis, Sarah, Upadhyay, Sameer, Singh, Teji, Rodino-Klapac, Louise
Format: Journal Article
Language:English
Published: Elsevier Inc 01-03-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1098-3600
1530-0366
DOI:10.1016/j.gim.2022.01.237